Table 2 Ultrasound and endoscopic findings in the two studied groups (n = 40, 100%)
Comparative factors | Group I: combined therapy group | Group II: EBL group | P value | ||
|---|---|---|---|---|---|
Mean/count | %/±SD | Mean/count | %/±SD | ||
Liver size | |||||
 Normal | 15 | 75% | 11 | 55% | 0.403 |
 Shrunken | 3 | 15% | 6 | 30% | |
 Enlarged | 2 | 10% | 3 | 15% | |
 Cirrhosis | 20 | 100% | 20 | 100% | 1 |
 Focal lesions | 1 | 5% | 0 | 0% | 0.311 |
 Portal fibrosis | 3 | 15% | 6 | 30% | 0.256 |
 Splenomegaly | 18 | 90% | 13 | 65% | 0.490 |
 Collaterals | 6 | 30% | 6 | 30% | 1 |
 Ascites | 11 | 55% | 11 | 55% | 0.861 |
 Portal vein dilatation | 17 | 85% | 12 | 60% | 0.077 |
Type of bleeding from GAVE | |||||
 Hematemesis ± melena | 5 | 25% | 4 | 20% | 0.927 |
 Melena alone | 12 | 60% | 13 | 65% | |
 Occult bleeding | 3 | 15% | 3 | 15% | |
Endoscopic picture of GAVE | |||||
 Punctuate type | 17 | 85% | 15 | 75% | 0.429 |
 Classic type | 3 | 15% | 5 | 25% | |